{"name":"Corxel Pharmaceuticals","slug":"corxel-pharmaceuticals","ticker":"","exchange":"","domain":"corxel.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Varenicline Tartrate Nasal Spray","genericName":"Varenicline Tartrate Nasal Spray","slug":"varenicline-tartrate-nasal-spray","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Varenicline Tartrate Nasal Spray","genericName":"Varenicline Tartrate Nasal Spray","slug":"varenicline-tartrate-nasal-spray","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQbjk0MFE4RS1kUjNWSFBrS1BoUkFkZUlaSmdvS3IyWW44b01HLUYzR0Vxd0Nnc01QRGtpbm5TSkdNUmNlTW8wcEZYM09sYTJlUGI1THV0Sl8yZkRMZk85QzYyRHRhSk93TXpGUWUzc3Qzc3owTnVEZmZHQUZXM29TdURIZW56RkhrbmVPLTJxaGRaWWRUalA4?oc=5","date":"2026-01-26","type":"pipeline","source":"FinSMEs","summary":"Corxel Pharmaceuticals Raises $287M in Series D1 Funding - FinSMEs","headline":"Corxel Pharmaceuticals Raises $287M in Series D1 Funding","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNbDJZd19HWklwMUtwU1cxTFFyMW1IX1JkYWthdUdLeG5xNEEwT2k1eUgyQlRVN0x1Z01CNzRZb1hlcU9YcFRXd180MTdIY3RwNGZnU2R1Ykl1U0VhMEVueHVXZU9lZ1NsaVFOVGJQWEQxTE10MlNsclpCaTBsaDFGUDFhbnlxUGpKdE9mSEJCUWw5SDFtVVFpM01pNHpYZF95dWc?oc=5","date":"2026-01-23","type":"pipeline","source":"Medical Marketing and Media","summary":"Rx Rundown: Bristol Myers Squibb, Corxel Pharmaceuticals, GSK and more - MM+M - Medical Marketing and Media - Medical Marketing and Media","headline":"Rx Rundown: Bristol Myers Squibb, Corxel Pharmaceuticals, GSK and more - MM+M - Medical Marketing and Media","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQU3pvVmFuaTVndFZBUkZiY05oSlJaX0RxREhqWUFxQ193OVBIbV9meVhhU3JhVUF2MUhMbHJCNkI5SHBYd3I3WjZpMnkyeTY5OUhOV2FjV2cxaHFjTllkNnB0N09wb0Y5al9tanVsOWU5M21URFVXUkJ6bFR3VnUxcURDaGJRRzJ3MUFQQ1dxSmUtT29SanRkOFZuVU1CODJ0UkQtMlpXWUZIejZ2UkFYbU84Wms?oc=5","date":"2026-01-23","type":"pipeline","source":"Pharmaceutical Technology","summary":"Corxel raises $287m as obesity continues to spark investor interest - Pharmaceutical Technology","headline":"Corxel raises $287m as obesity continues to spark investor interest","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOTFZ6d05kem9RaXBpbWFaTUdhMDhtNW1Qb3g4Rk5kdmRpNk9WLU5DcU1wZUNBZFZ1QkJsdUhEbzRtTjNUVDA5STFFcUVXM3RtX0x6cjhld3pHQnhJdWx2eVJ3V21aLXBqTnFQNWRXajVSMDFxeEhCWEo5MVk0WGJIcFpZZko1blVhdGxV?oc=5","date":"2026-01-23","type":"pipeline","source":"pharmaphorum","summary":"Corxel's raises $287m for obesity drug, and other financings - pharmaphorum","headline":"Corxel's raises $287m for obesity drug, and other financings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPQjVMd2ZNSGc4dXRmdnNwY2IxR09GNkNwVXg4Y0ZLdlctMHczY3JDLWhfT2lDODFIVXJKWnV2cHNZZndTMGdTZVRvTHl2V3RGS3dpSlhqUU5WUDJhbXBvRk5QOGt1MmZ3bFFZU2JUdkdhY3BYcHBldDF6cVFrWEo5OHJNbzdjSVlwUGFMMw?oc=5","date":"2026-01-23","type":"trial","source":"Endpoints News","summary":"China-rooted Corxel raises up to $287M for GLP-1 pill with global ambitions - Endpoints News","headline":"China-rooted Corxel raises up to $287M for GLP-1 pill with global ambitions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNOTNGakpMR0xhb3VUY0Z3RGNnRVFqaXBWRWZxUXZSMjV1WU1yRGEybW54U2ZtSnJsYW1RODFVWWh1Z3N1X0pGNEplWkVvS05GX2lzUC02Z3ZjM1NINWc4bXUwaUNxZzFMVjExZEctTzIzSE5vQnltd3ZMbXhJYzQ3NlctSmVSYTFCVU1OOFJtejVGcTJjZ1lfSzN0MDZ6UXF1RElKTjVR?oc=5","date":"2026-01-22","type":"trial","source":"Fierce Biotech","summary":"Corxel secures $287M series D to fund phase 2/3 obesity studies of oral GLP-1 drug - Fierce Biotech","headline":"Corxel secures $287M series D to fund phase 2/3 obesity studies of oral GLP-1 drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQQm12WkxFamhfM25PM1M3c0hvNnpuQnF4NkNOcHpnVjFpSHprNUhyVlBzTjlSaEw2Tk1XOGFpdkxQTS1rTk1GLXVMVEpDdUU5b3RfTUpraXY2MVJVMDVxZXRFNk00S0ZpQ2gzNGFuQWttbDVwQVZSamVhY3ltZGxqUC0zX1ZPZWNSbXo1VzFuOVMxSmdU?oc=5","date":"2026-01-22","type":"pipeline","source":"BioPharma Dive","summary":"Investors load Corxel with $287M for a ‘differentiated’ obesity pill - BioPharma Dive","headline":"Investors load Corxel with $287M for a ‘differentiated’ obesity pill","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPUi1BZkdaUVlPUHlUbWZKSVU5X3QwZ25nS0NaRTZFaUpTUUxKcUszdEs2amFkN0p0dkRzZnFjNzRoQm5FYXVsN0p2SjBuOVpqbWRySzhET2pka2RUMngyX1U0QWhBQldVMWtjSUNBelhUU3dhTVhWbTJXODhDdVh6Ny1Ra0RDVUFjRFFkYTZGVW5ZaFla?oc=5","date":"2026-01-22","type":"pipeline","source":"Axios","summary":"Corxel Pharma raises $287M Series D1 for cardiometabolic drugs - Axios","headline":"Corxel Pharma raises $287M Series D1 for cardiometabolic drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPUWFYejNNS0xiaDZOU1RGTW9aQ0FwUHBCV0pLbGNodnprekh6OWpla3d5TTJRZUpLMzZfRWxrMURQODlZTW54aFZJTVhCN3NMWU1uLVBuYjE2a3hhejN1Y0I5aXY2bHpzdlNaeEl4M3h1MkVuTmtxejRoZmxlYThXN1Uxd3NZWUdjS3FtbDBsc0ZFRVliNE1ybw?oc=5","date":"2026-01-22","type":"pipeline","source":"The Pharma Letter","summary":"Corxel raises $287 million in Series D1 financing - The Pharma Letter","headline":"Corxel raises $287 million in Series D1 financing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE16aExPQldMRHhmOXE2d01icnh6SmZkMVBRMklPX0hfQV9IWUtTOUR0NnNCVno2dmU5MEV3MVN2RjZfY1VrSlpldWpKWTJOYlFaYXhj?oc=5","date":"2026-01-22","type":"pipeline","source":"FirstWord Pharma","summary":"CORXEL banks $287M to advance oral GLP-1 candidate - FirstWord Pharma","headline":"CORXEL banks $287M to advance oral GLP-1 candidate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxNaUdUY0xlcUJrcmJPTUE5ZmhNd3pFTktQaGx0a0NvRVg2VGFwSmwzbDljS2VnVGQ4bHZMcS04ejQ5WWlDcGVWb2c2YU1iclNrWG1raDZtd21RSUhMYnFoOG9wMWV6Sy1EdUJCR2JJdmk3ZW51aEtDclZ6cGJqWUZFdjBXMGFNSjRUc2FpZ2NCWDRKQlV4M2JiWXlxV2ppSkp5OXowNHRpSFI0UGhaRTkwS2pMZ2l6eXBKLUlmZnhFYmE2VWM0eHpaWE14c1dmRFppUm4tbU9ROGtHVDZVYkMyU1kyUFRtRFpoM0pHZ0FnNTNXTmNITkhIZlgyM2hDOWZqc2tQNE53UnY1NG8?oc=5","date":"2025-07-28","type":"pipeline","source":"LENZ Therapeutics","summary":"LENZ Therapeutics Announces NMPA Submission of New Drug Application for LNZ100 in China for the Treatment of Presbyopia - LENZ Therapeutics","headline":"LENZ Therapeutics Announces NMPA Submission of New Drug Application for LNZ100 in China for the Treatment of Presbyopia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPLVg2eEJGTzJEVUJ2Y1lhRnc5SXdWM1htajFPVE5LTGxUNk8tQWh2N3RFaGE4X01XY3A3OUdIcVd6aDdxdnJ1MEUtMFh6UGJqaUp6bHNwb29mVDU3X0hoS3VTdHdkazdLajN4WnRhSXFLSW9MNjhWZmRRZUJ3dlRYelJvSkhjX3hOcW1mZGpZa1N2SXJWX2FseTVySzZtdWNMSkcxV3Zybw?oc=5","date":"2025-06-27","type":"deal","source":"fiercepharma.com","summary":"Fierce Pharma Asia—Vor-RemeGen, Otsuka-Harbour autoimmune deals; Datroway's lung cancer nod - fiercepharma.com","headline":"Fierce Pharma Asia—Vor-RemeGen, Otsuka-Harbour autoimmune deals; Datroway's lung cancer nod","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}